Mayne Pharma International Pty Ltd. v. Merck & Co., Inc., et al
REPORT AND RECOMMENDATIONS recommending GRANTING-IN-PART without prejudice D.I. 10 MOTION to Dismiss for Failure to State a Claim filed by Merck Sharp & Dohme Corp., Merck & Co., Inc., N.V. Organon. Please note that when filing Ob jections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 12/21/2015. Signed by Judge Christopher J. Burke on 12/3/2015. (mlc)
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?